001     185728
005     20240619092020.0
024 7 _ |a 10.1021/nn406388t
|2 doi
024 7 _ |a 1936-0851
|2 ISSN
024 7 _ |a 1936-086X
|2 ISSN
024 7 _ |a WOS:000333539400084
|2 WOS
024 7 _ |a altmetric:2152982
|2 altmetric
024 7 _ |a pmid:24548260
|2 pmid
037 _ _ |a FZJ-2014-07153
082 _ _ |a 540
100 1 _ |0 P:(DE-HGF)0
|a Schulz, Anita
|b 0
|e Corresponding Author
245 _ _ |a Drug-Induced Morphology Switch in Drug Delivery Systems Based on Poly(2-oxazoline)s
260 _ _ |a Washington, DC
|b Soc.
|c 2014
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1422610688_18118
|2 PUB:(DE-HGF)
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|0 0
|2 EndNote
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a article
|2 DRIVER
520 _ _ |a Defined aggregates of polymers such as polymeric micelles are of great importance in the development of pharmaceutical formulations. The amount of drug that can be formulated by a drug delivery system is an important issue, and most drug delivery systems suffer from their relatively low drug-loading capacity. However, as the loading capacities increase, i.e., promoted by good drug–polymer interactions, the drug may affect the morphology and stability of the micellar system. We investigated this effect in a prominent system with very high capacity for hydrophobic drugs and found extraordinary stability as well as a profound morphology change upon incorporation of paclitaxel into micelles of amphiphilic ABA poly(2-oxazoline) triblock copolymers. The hydrophilic blocks A comprised poly(2-methyl-2-oxazoline), while the middle blocks B were either just barely hydrophobic poly(2-n-butyl-2-oxazoline) or highly hydrophobic poly(2-n-nonyl-2-oxazoline). The aggregation behavior of both polymers and their formulations with varying paclitaxel contents were investigated by means of dynamic light scattering, atomic force microscopy, (cryogenic) transmission electron microscopy, and small-angle neutron scattering. While without drug, wormlike micelles were present, after incorporation of small amounts of drugs only spherical morphologies remained. Furthermore, the much more hydrophobic poly(2-n-nonyl-2-oxazoline)-containing triblock copolymer exhibited only half the capacity for paclitaxel than the poly(2-n-butyl-2-oxazoline)-containing copolymer along with a lower stability. In the latter, contents of paclitaxel of 8 wt % or higher resulted in a raspberry-like micellar core.
536 _ _ |0 G:(DE-HGF)POF2-54G24
|a 54G - JCNS (POF2-54G24)
|c POF2-54G24
|f POF II
|x 0
588 _ _ |a Dataset connected to CrossRef, juser.fz-juelich.de
650 2 7 |a Biology
|0 V:(DE-MLZ)SciArea-160
|2 V:(DE-HGF)
|x 0
650 2 7 |a Medicine
|0 V:(DE-MLZ)SciArea-190
|2 V:(DE-HGF)
|x 1
650 2 7 |a Chemistry
|0 V:(DE-MLZ)SciArea-110
|2 V:(DE-HGF)
|x 2
650 1 7 |a Health and Life
|0 V:(DE-MLZ)GC-130-2016
|2 V:(DE-HGF)
|x 2
650 1 7 |a Health and Life
|0 V:(DE-MLZ)GC-130-1
|2 V:(DE-HGF)
|x 1
650 1 7 |a Soft Matter, Macromolecules, Complex fluids, Biophysics
|0 V:(DE-MLZ)GC-140
|2 V:(DE-HGF)
|x 0
693 _ _ |0 EXP:(DE-MLZ)KWS1-20140101
|1 EXP:(DE-MLZ)FRMII-20140101
|5 EXP:(DE-MLZ)KWS1-20140101
|6 EXP:(DE-MLZ)NL3b-20140101
|a Forschungs-Neutronenquelle Heinz Maier-Leibnitz
|e KWS-1: Small angle scattering diffractometer
|f NL3b
|x 0
700 1 _ |0 P:(DE-Juel1)157910
|a Jaksch, Sebastian
|b 1
|u fzj
700 1 _ |0 P:(DE-HGF)0
|a Schubel, Rene
|b 2
700 1 _ |0 P:(DE-HGF)0
|a Wegener, Erik
|b 3
700 1 _ |0 P:(DE-Juel1)141663
|a Di, Zhenyu
|b 4
|u fzj
700 1 _ |0 P:(DE-HGF)0
|a Han, Yingchao
|b 5
700 1 _ |0 P:(DE-HGF)0
|a Meister, Annette
|b 6
700 1 _ |0 P:(DE-HGF)0
|a Kressler, Jörg
|b 7
700 1 _ |0 P:(DE-HGF)0
|a Kabanov, Alexander V.
|b 8
700 1 _ |0 P:(DE-HGF)0
|a Luxenhofer, Robert
|b 9
700 1 _ |0 P:(DE-HGF)0
|a Papadakis, Christine M.
|b 10
700 1 _ |0 P:(DE-HGF)0
|a Jordan, Rainer
|b 11
773 _ _ |0 PERI:(DE-600)2383064-5
|a 10.1021/nn406388t
|g Vol. 8, no. 3, p. 2686 - 2696
|n 3
|p 2686 - 2696
|t ACS nano
|v 8
|x 1936-086X
|y 2014
856 4 _ |u https://juser.fz-juelich.de/record/185728/files/FZJ-2014-07153.pdf
|y Restricted
909 C O |o oai:juser.fz-juelich.de:185728
|p VDB:MLZ
|p VDB
910 1 _ |0 I:(DE-588b)5008462-8
|6 P:(DE-Juel1)157910
|a Forschungszentrum Jülich GmbH
|b 1
|k FZJ
910 1 _ |0 I:(DE-588b)5008462-8
|6 P:(DE-Juel1)141663
|a Forschungszentrum Jülich GmbH
|b 4
|k FZJ
913 2 _ |0 G:(DE-HGF)POF3-600
|1 G:(DE-HGF)POF3
|2 G:(DE-HGF)POF
|9 G:(DE-HGF)POF3-6G15
|a DE-HGF
|b Programmorientierte Förderung
|l POF III
|v Forschungsbereich Materie
|x 0
913 2 _ |0 G:(DE-HGF)POF3-623
|1 G:(DE-HGF)POF3-620
|2 G:(DE-HGF)POF3-600
|9 G:(DE-HGF)POF3-6G4
|a DE-HGF
|b Forschungsbereich Materie
|l Von Materie zu Materialien und Leben
|v Facility topic: Neutrons for Research on Condensed Matter
|x 1
913 1 _ |0 G:(DE-HGF)POF2-54G24
|1 G:(DE-HGF)POF2-540
|2 G:(DE-HGF)POF2-500
|a DE-HGF
|b Struktur der Materie
|v JCNS
|x 0
|4 G:(DE-HGF)POF
|3 G:(DE-HGF)POF2
|l Forschung mit Photonen, Neutronen, Ionen
914 1 _ |y 2014
915 _ _ |0 StatID:(DE-HGF)0100
|2 StatID
|a JCR
915 _ _ |0 StatID:(DE-HGF)0110
|2 StatID
|a WoS
|b Science Citation Index
915 _ _ |0 StatID:(DE-HGF)0111
|2 StatID
|a WoS
|b Science Citation Index Expanded
915 _ _ |0 StatID:(DE-HGF)0150
|2 StatID
|a DBCoverage
|b Web of Science Core Collection
915 _ _ |0 StatID:(DE-HGF)0199
|2 StatID
|a DBCoverage
|b Thomson Reuters Master Journal List
915 _ _ |0 StatID:(DE-HGF)0200
|2 StatID
|a DBCoverage
|b SCOPUS
915 _ _ |0 StatID:(DE-HGF)0300
|2 StatID
|a DBCoverage
|b Medline
915 _ _ |0 StatID:(DE-HGF)0310
|2 StatID
|a DBCoverage
|b NCBI Molecular Biology Database
915 _ _ |0 StatID:(DE-HGF)1150
|2 StatID
|a DBCoverage
|b Current Contents - Physical, Chemical and Earth Sciences
915 _ _ |0 StatID:(DE-HGF)9910
|2 StatID
|a IF >= 10
920 1 _ |0 I:(DE-Juel1)JCNS-FRM-II-20110218
|k JCNS (München) ; Jülich Centre for Neutron Science JCNS (München) ; JCNS-FRM-II
|l JCNS-FRM-II
|x 0
920 1 _ |0 I:(DE-Juel1)JCNS-1-20110106
|k Neutronenstreuung ; JCNS-1
|l Neutronenstreuung
|x 1
920 1 _ |0 I:(DE-Juel1)ICS-1-20110106
|k ICS-1
|l Neutronenstreuung
|x 2
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-Juel1)JCNS-FRM-II-20110218
980 _ _ |a I:(DE-Juel1)JCNS-1-20110106
980 _ _ |a I:(DE-Juel1)ICS-1-20110106
980 _ _ |a UNRESTRICTED
981 _ _ |a I:(DE-Juel1)IBI-8-20200312
981 _ _ |a I:(DE-Juel1)JCNS-1-20110106
981 _ _ |a I:(DE-Juel1)ICS-1-20110106


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21